SEARCH

SEARCH BY CITATION

References

  • Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD, Lefkowitz RJ & Koch WJ (1997). Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A 94, 1210012105.
  • Arai M, Matsui H & Periasamy M (1994). Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74, 555564.
  • Askari AT, & Penn MS (2002). Targeted gene therapy for the treatment of cardiac dysfunction. Semin Thorac Cardiovasc Surg 14, 167177.
  • Bers DM, (2002a). Calcium and cardiac rhythms: physiological and pathophysiological. Circ Res 90, 1417.
  • Bers DM, (2002b). Cardiac excitation-contraction coupling. Nature 415, 198205.
  • Bers DM, (2002c). Cardiac Na/Ca exchange function in rabbit, mouse and man: What's the difference? J Mol Cell Cardiol 34, 369373.
  • Boeckstegers P, von Degenfeld G, Heinrich D, Hullin R, Kupatt C & Franz W (1999). Regional myocardial gene transfer using high efficiency with selective pressure-regulated retroinfusion of coronary veins. Circulation 100, I–184.
  • Brillantes AM, Allen P, Takahashi T, Izumo S & Marks AR (1992). Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 71, 1826 [published erratum appears in Circ Res 71, 1538]
  • Brillantes AM, Bezprozvannaya S & Marks AR (1994). Developmental and tissue-specific regulation of rabbit skeletal and cardiac muscle calcium channels involved in excitation-contraction coupling. Circ Res 75, 503510.
  • Brittsan AG, Carr AN, Schmidt AG & Kranias EG (2000). Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem 275, 1212912135.
  • Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Jing SL, Allen PB, Greengard P, Yatani A, Hoit BD, Grupp IL, Hajjar RJ, Depaoli-Roach AA & Kranias EG (2002). Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 22, 41244135.
  • Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A & Dachs GU (2002). Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 9, 399406.
  • Cheng H, Lederer MR, Xiao RP, Gomez AM, Zhou YY, Ziman B, Spurgeon H, Lakatta EG & Lederer WJ (1996). Excitation-contraction coupling in heart: new insights from Ca2+ sparks. Cell Calcium 20, 129140.
  • Chu G, Lester JW, Young KB, Luo W, Zhai J & Kranias EG (2000). A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J Biol Chem 275, 3893838943.
  • Chu G, Li L, Sato Y, Harrer JM, Kadambi VJ, Hoit BD, Bers DM & Kranias EG (1998). Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo. J Biol Chem 273, 3367433680.
  • Cordier L, Gao GP, Hack AA, McNally EM, Wilson JM, Chirmule N & Sweeney HL (2001). Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum Gene Ther 12, 205215.
  • Coutu P, & Metzger JM (2002). Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling. Biophys J 82, 25652579.
  • Davidoff AJ, & Gwathmey JK (1994). Pathophysiology of cardiomyopathies: Part I. Animal models and humans. Curr Opin Cardiol 9, 357368.
  • Davis AR, Wivel NA, Palladino JL, Tao L & Wilson JM (2001). Construction of adenoviral vectors. Mol Biotechnol 18, 6370.
  • del Monte F, Butler K, Boecker W, Gwathmey JK & Hajjar RJ (2002a). Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. Physiol Genomics 9, 4956.
  • del Monte F, Harding SE, Dec GW, Gwathmey JK & Hajjar RJ (2002b). Targeting phospholamban by gene transfer in human heart failure. Circulation 105, 904907.
  • del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, Gwathmey JK, Rosenzweig A & Hajjar RJ (1999). Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100, 23082311.
  • del Monte F, Williams E, Lebeche D, Schmidt U, Rosenzweig A, Gwathmey JK, Lewandowski DE & Hajjar RJ (2001). Improvement in survival and cardiac metabolism following gene transfer of SERCA2a in a rat model of heart failure. Circulation 104, 14241429.
  • Desai KH, Schauble E, Luo W, Kranias E & Bernstein D (1999). Phospholamban deficiency does not compromise exercise capacity Am J Physiol 276, H11721177.
  • Donahue JK, Kikkawa K, Johns DC, Marban E & Lawrence JH (1997). Ultrarapid highly efficient viral gene transfer to the heart. Proc Natl Acad Sci US A94, 46644668.
  • Donahue JK, Kikkawa K, Thomas AD, Marban E & Lawrence JH (1998). Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Therapy 5, 630634.
  • Du XJ, Autelitano DJ, Dilley RJ, Wang B, Dart AM & Woodcock EA (2000). β2-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation 101, 7177.
  • Engelhardt S, Hein L, Wiesmann F & Lohse MJ (1999). Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 96, 70597064.
  • Force T, Hajjar R, del Monte F, Rosenzweig A & Choukroun G (1999). Signaling pathways mediating the response to hypertrophic stress in the heart. Gene Expr 7, 337348.
  • Frank K, & Kranias EG (2000). Phospholamban and cardiac contractility. Ann Med 32, 572578.
  • Fromes Y, Salmon A, Wang X, Collin H, Rouche A, Hagege A, Schwartz K & Fiszman MY (1999). Gene delivery to the myocardium by intrapericardial injection. Gene Therapy 6, 683688.
  • Fuchs S, Baffour R, Shou M, Stabile E, Singh S, Schwartz B, Branellec D, Epstein SE & Kornowski R (2001). Could plasmid-mediated gene transfer into the myocardium be augmented by left ventricular guided laser myocardial injury? Catheter Cardiovasc Interv 54, 533538.
  • Gao GP, Wilson JM & Wivel NA (2000b). Production of recombinant adeno-associated virus. Adv Virus Res 55, 529543.
  • Goins WF, Krisky DM, Wolfe DP, Fink DJ & Glorioso JC (2002). Development of replication-defective herpes simplex virus vectors. Methods Mol Med 69, 481507.
  • Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA & Lederer WJ (1997). Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276, 800806.
  • Greene AL, Lalli MJ, Ji Y, Babu GJ, Grupp I, Sussman M & Periasamy M (2000). Overexpression of SERCA2b in the heart leads to an increase in sarcoplasmic reticulum calcium transport function and increased cardiac contractility. J Biol Chem 275, 2472224727.
  • Gruver EJ, Glass MG, Marsh JD & Gwathmey JK (1993). An animal model of dilated cardiomyopathy: characterization of dihydropyridine receptors and contractile performance. Am J Physiol 265, H17041711.
  • Guzman RJ, Lemarchand P, Crystal RG, Epstein SE & Finkel T (1993). Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 73, 12021207.
  • Gwathmey JK, Bentivegna LA, Ransil BJ, Grossman W & Morgan JP (1993). Relationship of abnormal intracellular calcium mobilisation to myocyte hypertrophy in human ventricular myocardium. Cardiovasc Res 27, 199203.
  • Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W & Morgan JP (1987). Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61, 7076.
  • Gwathmey JK, & Hajjar RJ (1990). Relation between steady-state force and intracellular [Ca2+] in intact human myocardium. Index of myofibrillar responsiveness to Ca2+. Circulation 82, 12661278.
  • Gwathmey JK, & Morgan JP (1985). Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res 57, 836843.
  • Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM & Morgan JP (1990). Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85, 15991613.
  • Hajjar RJ, del Monte F, Matsui T & Rosenzweig A (2000a). Prospects for gene therapy for heart failure. Circ Res 86, 61621.
  • Hajjar RJ, Kang JX, Gwathmey JK & Rosenzweig A (1997a). Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation 95, 423429.
  • Hajjar RJ, Schmidt U, Kang JX, Matsui T & Rosenzweig A (1997b). Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca2+ ATPase. Circ Res 81, 145153.
  • Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, Dec GW, Semigran MJ & Rosenzweig A (1998). Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A 95, 52515256.
  • Hajjar RJ, Schwinger RH, Schmidt U, Kim CS, Lebeche D, Doye AA & Gwathmey JK (2000b). Myofilament calcium regulation in human myocardium. Circulation 101, 16791685.
  • Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B & Just H (1994a). Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 15, 164170.
  • Hasenfuss G, Pieske B, Holubarsch C, Alpert NR & Just H (1993). Excitation-contraction coupling and contractile protein function in failing and nonfailing human myocardium. Adv Exp Med Biol 346, 91100.
  • Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H & Drexler H (1994b). Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75, 434442.
  • Hasenfuss G, Reinecke H, Studer R, Pieske B, Meyer M, Drexler H & Just H (1996). Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol 91, suppl. 2, 1722.
  • Hasenfuss G, Schillinger W, Lehnart SE, Preuss M, Pieske B, Maier LS, Prestle J, Minami K & Just H (1999). Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99, 641648.
  • He H, Meyer M, Martin JL, McDonough PM, Ho P, Lou X, Lew WY, Hilal-Dandan R & Dillmann WH (1999). Effects of mutant and antisense RNA of phospholamban on SR Ca2+-ATPase activity and cardiac myocyte contractility. Circulation 100, 974980.
  • Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross J Jr & Chien KR (2002). Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8, 864871.
  • Ikeda Y, Gu Y, Iwanaga Y, Hoshijima M, Oh SS, Giordano FJ, Chen J, Nigro V, Peterson KL, Chien KR & Ross J Jr (2002). Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation 105, 502508.
  • Isner JM, (2002). Myocardial gene therapy. Nature 415, 234239.
  • Izu LT, Wier WG & Balke CW (2001). Evolution of cardiac calcium waves from stochastic calcium sparks. Biophys J 80, 10320.
  • Johnson RG Jr & Kranias EG (1998). Cardiac sarcoplasmic reticulum function and regulation of contractility. Introduction. Ann N Y Acad Sci 853, xi–xvi.
  • Kadambi VJ, & Kranias EG (1998). Genetically engineered mice: model systems for left ventricular failure. J Card Fail 4, 349361.
  • Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW II, Walsh RA & Kranias EG (1996). Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 97, 533539.
  • Koss KL, & Kranias EG (1996). Phospholamban: A prominent regulator of myocardial contractility. Circ Res 79, 10591063.
  • Lai NC, Roth DM, Gao MH, Fine S, Head BP, Zhu J, McKirnan MD, Kwong C, Dalton N, Urasawa K, Roth DA & Hammond HK (2000). Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation 102, 23962401.
  • Li L, Desantiago J, Chu G, Kranias EG & Bers DM (2000). Phosphorylation of phospholamban and troponin I in beta-adrenergic- induced acceleration of cardiac relaxation. Am J Physiol 278, H769779.
  • Li Y, Kranias EG, Mignery GA & Bers DM (2002). Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 90, 309316.
  • Logeart D, Hatem SN, Rucker-Martin C, Chossat N, Nevo N, Haddada H, Heimburger M, Perricaudet M & Mercadier JJ (2000). Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum Gene Ther 11, 10151022.
  • Loukianov E, Ji Y, Baker DL, Reed T, Babu J, Loukianova T, Greene A, Shull G & Periasamy M (1998). Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. Ann N Y Acad Sci 853, 251259.
  • Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T & Kranias EG (1994). Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75, 401409.
  • Maier LS, Bers DM & Pieske B (2000). Differences in Ca2+-handling and sarcoplasmic reticulum Ca2+-content in isolated rat and rabbit myocardium. J Mol Cell Cardiol 32, 22492258.
  • Marban E, (2002). Cardiac channelopathies. Nature 415, 213218.
  • Marks AR, (1997). Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 272, H597605.
  • Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N & Marks AR (2000). PKA phosphorylation dissociates FKBP126 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365376.
  • Maurice JP, Hata JA, Shah AS, White DC, McDonald PH, Dolber PC, Wilson KH, Lefkowitz RJ, Glower DD & Koch WJ (1999). Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest 104, 2129.
  • Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J Jr, Kranias EG, Giles WR & Chien KR (1999). Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313322.
  • Miyamoto MI, del Monte F, Schmidt U, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A & Hajjar RJ (2000). Adenoviral gene transfer of SERCA2a improves left ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 97, 793798.
  • Ng P, Beauchamp C, Evelegh C, Parks R & Graham FL (2001). Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Mol Ther 3, 809815.
  • Ng P, Evelegh C, Cummings D & Graham FL (2002). Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system. J Virol 76, 41814189.
  • Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U & Graham FL (1999). A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 10, 26672672.
  • Pieske B, Maier LS, Bers DM & Hasenfuss G (1999). Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ Res 85, 3846.
  • Pogwizd SM, Qi M, Yuan W, Samarel AM & Bers DM (1999). Upregulation of Na+/Ca2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 85, 10091019.
  • Pogwizd SM, Schlotthauer K, Li L, Yuan W & Bers DM (2001). Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88, 11591567.
  • Ranu HK, Terracciano CM, Davia K, Bernobich E, Chaudhri B, Robinson SE, Bin Kang Z, Hajjar RJ, Macleod KT & Harding SE (2002). Effects of Na+/Ca2+-exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. J Mol Cell Cardiol 34, 389400.
  • Rasmussen RP, Minobe W & Bristow MR (1990). Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Biochem Pharmacol 39, 691696.
  • Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ & Koch WJ (1998). Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A 95, 70007005.
  • Sato Y, Kiriazis H, Yatani A, Schmidt AG, Hahn H, Ferguson DG, Sako H, Mitarai S, Honda R, Mesnard-Rouiller L, Frank KF, Beyermann B, Wu G, Fujimori K, Dorn GW II & Kranias EG (2001). Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J Biol Chem 276, 93929399.
  • Schmidt U, del Monte F, Miyamoto MI, Matsui T, Gwathmey JK, Rosenzweig A & Hajjar RJ (2000). Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca2+-ATPase. Circulation 101, 790796.
  • Schmidt U, Hajjar RJ, Helm PA, Kim CS, Doye AA & Gwathmey JK (1998). Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol 30, 19291937.
  • Schmidt U, Hajjar RJ, Kim CS, Lebeche D, Doye AA & Gwathmey JK (1999). Human heart failure: cAMP stimulation of SR Ca2+-ATPase activity and phosphorylation level of phospholamban. Am J Physiol 277, H474480.
  • Schnepp B, & Clark KR (2002). Highly purified recombinant adeno-associated virus vectors preparation and quantitation. Methods Mol Med 69, 427443.
  • Schwinger RH, Bohm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG & Erdmann E (1995). Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92, 32203228.
  • Schwinger RH, Brixius K, Savvidou-Zaroti P, Bolck B, Zobel C, Frank K, Kranias EG, Hoischen S & Erdmann E (2000). The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in Ca2+-sensitivity or myosin ATPase- activity of the contractile proteins. Basic Res Cardiol 95, 1218.
  • Schwinger RH, Munch G, Bolck B, Karczewski P, Krause EG & Erdmann E (1999). Reduced Ca2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 31, 479491.
  • Shi CX, Hitt M, Ng P & Graham FL (2002). Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors. Hum Gene Ther 13, 211224.
  • Stevenson LW, (1998). Inotropic therapy for heart failure. N Engl J Med 339, 18481850.
  • Svensson EC, Marshall DJ, Woodard K, Lin H, Jiang F, Chu L & Leiden JM (1999). Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 99, 201205.
  • Szatkowski ML, Westfall MV, Gomez CA, Wahr PA, Michele DE, Dellorusso C, Turner II, Hong KE, Albayya FP & Metzger JM (2001). In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J Clin Invest 107, 191198.
  • Takahashi T, Allen PD, Lacro RV, Marks AR, Dennis AR, Schoen FJ, Grossman W, Marsh JD & Izumo S (1992). Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 90, 927935.
  • Thuerauf DJ, Hoover H, Meller J, Hernandez J, Su L, Andrews C, Dillmann WH, McDonough PM & GlembotskI, CC (2001). Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J Biol Chem 276, 4830948317.
  • Towbin JA, & Bowles NE (2002). The failing heart. Nature 415, 227233.
  • Wahr PA, Michele DE & Metzger JM (1999). Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes. Proc Natl Acad Sci U S A 96, 1198211985.
  • Watson DJ, Kobinger GP, Passini MA, Wilson JM & Wolfe JH (2002). Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, ebola, mokola, LCMV, or MuLV envelope proteins. Mol Ther 5, 528537.
  • Wattanapitayakul SK, & Bauer JA (2000). Recent developments in gene therapy for cardiac disease. Biomed Pharmacother 54, 487504.
  • Wier WG, & Balke CW (1999). Ca2+ release mechanisms, Ca2+ sparks, and local control of excitation-contraction coupling in normal heart muscle. Circ Res 85, 770776.
  • Wu KD, Lee WS, Wey J, Bungard D & Lytton J (1995). Localization and quantification of endoplasmic reticulum Ca2+-ATPase isoform transcripts. Am J Physiol 269, C775784.